WilliamThomasCreasmanMD

Obstetrics & Gynecology • Charleston, SC

Gynecologic Oncology

Professor of Obstetrics & Gynecology, Med University SC

Join to view full profile

Dr. Creasman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Creasman's full profile

Already have an account?

Office
171 Ashley Ave
Charleston, SC 29425
Phone+1 843-792-9300

Fax+1 843-792-7799
Is this information wrong?

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1967 - 1969
University of RochesterResidency, Obstetrics and Gynecology, 1966 - 1967
University of RochesterResidency, Obstetrics and Gynecology, 1963 - 1965
Baylor College of MedicineClass of 1960

Certifications & Licensure

SC State Medical License 1986 - 2025
AZ State Medical License 1967 - 1999
TX State Medical License 1960 - 1998
NC State Medical License 1970 - 1998
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Clinical Trials

Screening of Bone Mineral Density in Women Who Have Received Chemotherapy Start of enrollment: 2006 Nov 01
Completed

Publications & Presentations

PubMed

Letter to the Editor: 2023 FIGO staging system for endometrial cancer.
Raspagliesi, F., Bogani, G., Pecorelli, S., Creasman, W.> ;International Journal of Gynaecology and Obstetrics. 2024 Jan 1
A Case for the Conservative Management of Stage IA Cervical Cancer.
Alexandra Blackman, William Creasman> ;Cancers. 2023 Oct 19
1 citations
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic...
Ian S Hagemann, Wei Deng, Richard J Zaino, Matthew A Powell, Camille Gunderson Jackson, Casey Cosgrove, Cara Mathews, Michael L Pearl, Steven Waggoner, Rahel Ghebre, S...> ;Gynecologic Oncology. 2023 Oct 1
8 citations
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group...
Ian S. Hagemann, Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille C. Gunderson, Casey Cosgrove, Cara Mathews, Michael L. Pearl, Steven E. Waggoner, Rahel G Ghebr...> ;Gynecologic Oncology. 2021 Mar 1
15 citations
Surgical training in gynecologic oncology: Past, present, future.
Mitchel S. Hoffman, Dennis S. Chi, Daniel L. Clarke-Pearson, William A. Cliby, William T. Creasman, Paul B. Underwood> ;Gynecologic Oncology. 2020 Jul 1
12 citations
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study
Ashley S. Felix, David E. Cohn, Theodore M. Brasky, Richard J. Zaino, Kay J. Park, David G. Mutch, William T. Creasman, Premal H. Thaker, Joan L. Walker, Richard G. Mo...> ;American Journal of Obstetrics and Gynecology. 2018 Nov 1
20 citations
Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.
Ashley S. Felix, Theodore M. Brasky, David E. Cohn, David G. Mutch, William T. Creasman, Premal H. Thaker, Joan L. Walker, Richard G. Moore, Shashikant Lele, Saketh R....> ;International Journal of Cancer. 2018 Mar 15
76 citations
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer
Casey Cosgrove, David Tritchler, David E. Cohn, David G. Mutch, Craig M. Rush, Heather A. Lankes, William T. Creasman, David Miller, Nilsa C. Ramirez, Melissa A. Gelle...> ;Gynecologic Oncology. 2018 Jan 1
10 citations
Why do we continue to overtreat stage Ia carcinoma of the cervix
Tommy R. Buchanan, Jennifer Young Pierce, Whitney Graybill, Matthew F. Kohler, William T. Creasman> ;American Journal of Obstetrics and Gynecology. 2017 Oct 1
20 citations
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Onco...
Eric J. Devor, Jeffrey C. Miecznikowski, Brandon M. Schickling, Jesus Gonzalez-Bosquet, Heather A. Lankes, Premal H. Thaker, Peter A. Argenta, Michael L. Pearl, Susan ...> ;Gynecologic Oncology. 2017 Dec 1
342 citations
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncolog...
Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson, Helen Huang, Lois M. Ramondetta, Lisa M. Landrum, Ana Oaknin, Thomas J. Reid, Mario M. Leitao, Helen Michael,...> ;Lancet. 2017 Oct 7
48 citations
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol ☆
William T. Creasman, Shamshad Ali, David G. Mutch, Richard J. Zaino, Matthew A. Powell, Robert S. Mannel, Floor J. Backes, Paul DiSilvestro, Peter A. Argenta, Michael ...> ;Gynecologic Oncology. 2017 Jun 1
8 citations
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.
Theodore M Brasky, Ashley S Felix, David E Cohn, D Scott McMeekin, David G Mutch, William T Creasman, Premal H Thaker, Joan L Walker, Richard G Moore, Shashikant B Lel...> ;Journal of the National Cancer Institute. 2017 Mar 1
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.
Brasky TM, Felix AS, Cohn DE, McMeekin DS, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Iof...> ;J. Natl. Cancer Inst.. 2017-03-01
8 citations
Concurrent chemoradiation versus radiotherapy alone for the treatment of locally advanced cervical cancer in a low-resource setting
Elena Pereira, Hoover Henriquez Cooper, Pedro Guillermo Zelaya, William T. Creasman, F.V. Price, Vishal Gupta, Linus Chuang> ;Gynecologic Oncology Reports. 2017 Feb 1
10 citations
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
Abigail Winder, Kruti P. Maniar, Jian-Jun Wei, Dachao Liu, Denise M. Scholtens, John R. Lurain, Julian C. Schink, Barbara M. Buttin, Virginia L. Filiaci, Heather A. La...> ;Cancer. 2017 Apr 1
5 citations
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic ...
Peter G. Rose, James J. Java, Mark A. Morgan, A. Alvarez-Secord, Joshua Kesterson, Frederick B. Stehman, David P. Warshal, William T. Creasman, Parviz Hanjani, Robert ...> ;Gynecologic Oncology. 2016 Dec 1
18 citations
Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases?
Shelby A. Neal, Whitney Graybill, Elizabeth Garrett-Mayer, Misty L. McDowell, Virginia E. McLean, C.H. Watson, Jennifer Young Pierce, Matthew F. Kohler, William T. Cre...> ;Gynecologic Oncology. 2015 Apr 1
8 citations
Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource Countries
Linus Chuang, Margaux J. Kanis, Brigitte Miller, Jason Wright, William Small, William T. Creasman> ;American Journal of Clinical Oncology. 2016 Feb 1
20 citations
The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study
Rodney P. Rocconi, Heather A. Lankes, W.E. Brady, Paul J. Goodfellow, Nilsa C. Ramirez, Ronald D. Alvarez, William T. Creasman, Jose R. Fernandez> ;Gynecologic Oncology. 2016 Feb 1
22 citations
Associations between etiologic factors and mortality after endometrial cancer diagnosis: The NRG Oncology/Gynecologic Oncology Group 210 trial
Ashley S. Felix, D. Scott McMeekin, David G. Mutch, Joan L. Walker, William T. Creasman, David E. Cohn, Shamshad Ali, Richard G. Moore, Levi S. Downs, Olga B. Ioffe, K...> ;Gynecologic Oncology. 2015 Oct 1
26 citations
Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/Gynecologic Oncology Group 210 Trial
Ashley S. Felix, Louise A. Brinton, D. Scott McMeekin, William T. Creasman, David G. Mutch, David E. Cohn, Joan L. Walker, Richard G. Moore, Levi S. Downs, Robert A. S...> ;Journal of the National Cancer Institute. 2015 Sep 1
11 citations
Teaching gynecologic oncology in Low resource settings: a collaboration of health volunteers overseas and the society of gynecologic oncology.
Linus Chuang, Kathleen N. Moore, William T. Creasman, Annekathryn Goodman, Hoover Henriquez Cooper, F.V. Price, Michael G. Conner, Vishal Gupta, Holly H. Gallion, Nade...> ;Gynecologic Oncology. 2014 Dec 1
145 citations
Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.
Louise A. Brinton, Ashley S. Felix, D. Scott McMeekin, William T. Creasman, Mark E. Sherman, David G. Mutch, David E. Cohn, Joan L. Walker, Richard G. Moore, Levi S. D...> ;Gynecologic Oncology. 2013 May 1
39 citations
Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells.
Mourad Wagdy Ali, Ercan Cacan, Yuying Liu, Jennifer Young Pierce, William T. Creasman, Mandi M. Murph, Rajgopal Govindarajan, Scott T. Eblen, Susanna F. Greer, Shelley...> ;Plos One. 2013 Mar 22
Join now to see all

Journal Articles

Endometrial Carcinoma Recurrence According to Race and Ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study
M L Pearl, D S Miller, W T Creasman, P H Thaker, J F Boggess, S R Guntupalli, D G Mutch, J L Walker, O B Ioffe, D E Cohn, L S Downs, International Journal of Cancer